Covered recipient · General Payments record
MEGHAN POLLARD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,862.63
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $936.23 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $196.73 | 7 |
| Inspire Medical Systems, Inc. | $171.38 | 1 |
| ITI, Inc. | $125.00 | 1 |
| Alexion Pharmaceuticals, Inc. | $124.56 | 1 |
| ABBVIE INC. | $122.58 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $121.56 | 1 |
| Novo Nordisk AS | $37.63 | 2 |
| Lilly USA, LLC | $19.04 | 1 |
| DEXCOM, INC. | $17.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $122.58 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108027589 | CMS |
| Alexion Pharmaceuticals, Inc. | $124.56 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093983436 | CMS |
| Amgen Inc. | $11.34 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117657543 | CMS |
| Amgen Inc. | $14.68 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117657545 | CMS |
| Amgen Inc. | $7.37 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117657547 | CMS |
| Amgen Inc. | $122.53 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117355505 | CMS |
| Amgen Inc. | $15.46 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117657549 | CMS |
| Amgen Inc. | $7.50 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117657551 | CMS |
| Amgen Inc. | $17.85 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117355503 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $121.56 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118155671 | CMS |
| Dexcom, Inc. | $17.75 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153378351 | CMS |
| Inspire Medical Systems, Inc. | $171.38 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148165729 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $125.00 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143583863 | CMS |
| Lilly USA, LLC | $19.04 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135745272 | CMS |
| Novo Nordisk Inc | $19.73 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100279388 | CMS |
| Novo Nordisk Inc | $17.90 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100571742 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.